Genotype testing in HIV-infected pregnant women

Background: Published guidelines recommend HIV genotype resistance testing for all pregnant women with detectable viraemia, regardless of antiretroviral therapy (ART) exposure, enabling to optimize ART. Objectives: To identify different HIV subtypes in pregnant women and correlate them with epidemiological factors. Supplement: Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection http://www.biomedcentral.com/content/pdf/1758-2652-13-S4-info.pdf Conference: Tenth International Congress on Drug Therapy in HIV Infection 7-11 November 2010 Glasgow, UK (Published: 8 November 2010) doi:10.1186/1758-2652-13-S4-P145 Cite this article as: Afonso et al.: Genotype testing in HIV-infected pregnant women. Journal of the International AIDS Society 2010 13(Suppl 4):P145. Full text: PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112922/